Table 2.
IVF-ET data and clinical outcomes
| Control (n = 34) | DNG (n = 30) | p | |
|---|---|---|---|
| Oocytes retrieved (n) | 7.5 ± 4.2 | 5.0 ± 3.6 | P < 0.01 |
| Mature oocytes (n) | 6.6 ± 3.9 | 4.1 ± 3.1 | P < 0.01 |
| Fertilized oocytes (n) | 5.0 ± 3.2 | 2.8 ± 2.8 | P < 0.01 |
| Fertilization rate (%) | 68.0 ± 23.4 | 53.7 ± 33.0 | P < 0.01 |
| Blastocysts (n) | 3.9 ± 2.9 | 1.5 ± 1.7 | P < 0.01 |
| Embryos transferred (n) | 68 | 44 | |
| Gestational sacs (n) | 24 | 11 | |
| Implantation rate (%) | 35.3 (24/68) | 25.0 (11/44) | ns |
| Pregnancy rate (%) | 67.6 (23/34) | 33.7 (11/30) | P < 0.05 |
| Live birth rate (%) | 52.9 (18/34) | 23.3 (7/30) | P < 0.05 |
| Abortion rate (%) | 25.0 (6/24) | 36.4 (4/11) | ns |
IVF-ET in vitro fertilization and embryo transfer, DNG dienogest, rASRM revised American society for reproduction medicine, FSH follicle-stimulating hormone, HMG human menopausal gonadotropin